100g

Racepinephrine Hydrochloride, USP

Raffinose, Pentahydrate

Molecular Formula : C44 H70 O23

Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.

Reinecke Salt, Monohydrate, Reagent, ACS

Molecular Formula : C6 H6 O2

Rhodamine 6G

Rhodamine B

Molecular Formula : C28 H31 N2 O3 . Cl

Rhodamine B Base, Alcohol Soluble

Ribavirin, USP

Riboflavin, FCC

Riboflavin, USP

Ribonucleic Acid

Molecular Formula : C15 H13 Cl2 N5 . Cl H

ROR1 (Receptor tyrosine kinase-like orphan receptor 1), also known as neurotrophic tyrosine kinase receptor-related 1 (NTRKR1), is a member of the ROR family within the receptor tyrosine kinases (RTK) superfamily. Two ROR family members (ROR1 and ROR2) have been identified and are characterized by the intracellular tyrosine kinase domains, highly related to those of the Trk-family receptor tyrosine kinases, and by the extracellular Frizzled-like cysteine-rich domains and kringle domains, which are common to receptors of the Wnt family members.

Rose Hips, Extract, 4:1, Powder

RRR-Vitamin E Succinate, 1 mg = 0.81 alpha-tocopherol equivalents, USP

Rubidium Chloride, High Purity

Rubidium Sulfate

Rutin, Powder

S-(+)-Mandelic Acid

S-Carboxymethyl-L-cysteine

Molecular Formula : C4 H9 N O2 S

Molecular Formula : C7 H4 N O3 S . Na . 2 H2 O

Saccharin Sodium, Dihydrate, Crystalline, USP

Saccharin Sodium, Dihydrate, Powder, USP

Safranine O

Salcomine, [=N,N’-Bis(salicylidene)ethylenediiminocobalt(II)]

Salicin

Salicylaldehyde

Molecular Formula : C7 H6 O2

Salicylaldoxime

Molecular Formula : C7 H7 N O2

Molecular Formula : C3 H7 N O2

Sarcosine

Sarcosine, Ultrapure

GenScript SARS-CoV-2 ADE-Causing Antibody (S9HC) reacts with SARS-CoV-2 Spike protein of wild type and delta variant. It can obviously enhance the SARS-COV-2 binding with ACE2.

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain. The product can recognize and neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha, Beta, Delta, and Omicron. Reactivity with Gamma variant has not been tested.

The product is specific for SARS-CoV-2 Nucleocapsid protein.

The product is specific for SARS-CoV-2 Nucleocapsid protein.

The product is specific for SARS-CoV-2 Nucleocapsid protein.

The product is specific for SARS-CoV-2 Nucleocapsid protein.

The product is specific for SARS-CoV-2 Nucleocapsid protein.

The product is specific for SARS-CoV-2 Nucleocapsid protein.

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus.

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is the most abundant structural protein of the coronavirus which is associated with the nucleic acid. The sublineage B.1.617.2 has been redesignated as a “variant of concern” (VOC-21APR-02) in May 2021, which spreads more quickly than the original version of the virus.